mSQUASH 是一种可行且有效的测量工具,用于统一评估风湿病患者日常身体活动
本研究将荷兰语 mSQUASH 翻译为英语并按 Beaton 流程进行跨文化调适,在轴性脊柱关节炎、舍格伦病、系统性红斑狼疮和巨细胞动脉炎/风湿性多肌痛患者中进行半结构化访谈,并在轴性脊柱关节炎患者中验证结构效度、重测信度和反应性。结果显示 mSQUASH 具有良好的语言和表面效度,临床验证证实其在轴性脊柱关节炎患者中具有良好结构效度、重测信度和反应性,支持在临床实践和研究中使用。
要点
- mSQUASH 英语版经 Beaton 流程翻译和跨文化调适成功完成,仅需少量修改和澄清。
- 在轴性脊柱关节炎患者中,mSQUASH 与 Axial Spondyloarthritis Disease Activity Score(ρ=-0.31)、Bath Ankylosing Spondylitis Functional Index(ρ=-0.37)和 Assessment of SpondyloArthritis International Society-Health Index(ρ=-0.30)呈中等相关。
- 重测信度非常好(ICC:0.87),反应性与自我报告身体活动变化方向一致(改善 SRM:0.72,稳定 SRM:0.06,恶化 SRM:-0.74)。
核心结论
- mSQUASH 在不同风湿病的现场测试中显示出良好的语言和表面效度,临床验证证实其在轴性脊柱关节炎患者中具有良好的结构效度、重测信度和反应性,支持在临床实践和研究中使用 mSQUASH。
研究设计与样本
- 将荷兰语 mSQUASH 按前向-后向 Beaton 流程翻译为英语,并在轴性脊柱关节炎(n=13)、舍格伦病(n=10)、系统性红斑狼疮(n=10)和巨细胞动脉炎/风湿性多肌痛(n=10)的代表性患者样本中进行半结构化访谈。
- 结构效度分析纳入 n=95,使用 Spearman 相关系数与临床结局评估进行相关分析。
- 重测信度分析纳入 n=82,计算组内相关系数(ICC)。
- 反应性分析纳入 n=80,按 Anchor 方法分层计算标准化反应均值(SRM)。
主要发现
- mSQUASH 英语翻译和跨文化调适成功完成,可作为其他翻译的基础,仅实施了少量修改和澄清。
- mSQUASH 与 Axial Spondyloarthritis Disease Activity Score 呈中等相关(ρ=-0.31),与 Bath Ankylosing Spondylitis Functional Index 呈中等相关(ρ=-0.37),与 Assessment of SpondyloArthritis International Society-Health Index 呈中等相关(ρ=-0.30)。
- 重测信度非常好(ICC:0.87)。
- 反应性与自我报告身体活动变化方向一致:改善者 SRM:0.72,稳定者 SRM:0.06,恶化者 SRM:-0.74。
关键数值与推荐
- mSQUASH 与 Axial Spondyloarthritis Disease Activity Score 的 Spearman 相关系数 ρ=-0.31。
- mSQUASH 与 Bath Ankylosing Spondylitis Functional Index 的 Spearman 相关系数 ρ=-0.37。
- mSQUASH 与 Assessment of SpondyloArthritis International Society-Health Index 的 Spearman 相关系数 ρ=-0.30。
- 重测信度组内相关系数 ICC:0.87。
- 反应性标准化反应均值:改善者 SRM:0.72,稳定者 SRM:0.06,恶化者 SRM:-0.74。
临床怎么用
- 原文结论支持在临床实践和研究中使用 mSQUASH 评估轴性脊柱关节炎患者的日常身体活动。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The modified Short QUestionnaire to ASsess Health-enhancing physical activity (mSQUASH) was originally developed and validated in Dutch patients with axial spondyloarthritis (axSpA). To support world-wide distribution, applicability and comparability of measuring physical activity, our aim was to perform translation and cross-cultural adaptation of the mSQUASH into English, field testing in other rheumatic diseases and clinical validation in patients with axSpA. METHODS: The Dutch mSQUASH was translated into English according to forward-backward Beaton protocol. Semistructured interviews were conducted in representative samples of patients with axSpA (n=13), Sjögren's disease (n=10), systemic lupus erythematosus (n=10) and giant cell arteritis/polymyalgia rheumatica (n=10) to verify relevance, comprehensiveness and comprehensibility. For construct validity (n=95), Spearman correlations were used with clinical outcome assessments. For test-retest reliability (n=82), intraclass correlation coefficients (ICC) were calculated. For responsiveness (n=80), standardised response means (SRM) were calculated stratified by Anchor method. RESULTS: Translation and cross-cultural adaptation of the mSQUASH into English were successfully carried out, which can serve as basis for other translations. Only minor adaptations and clarifications were implemented. Fair correlations were found between mSQUASH and Axial Spondyloarthritis Disease Activity Score (ρ=-0.31), Bath Ankylosing Spondylitis Functional Index (ρ=-0.37) and Assessment of SpondyloArthritis International Society-Health Index (ρ=-0.30). Test-retest reliability was very good (ICC: 0.87). Responsiveness corresponded to the direction of self-reported changes in physical activity (SRM: 0.72 for improved, 0.06 for stable and -0.74 for worsened). CONCLUSION: The mSQUASH showed good linguistic and face validity according to field testing in different rheumatic diseases. Clinical validation confirmed good construct validity, test-retest reliability and responsiveness in patients with axSpA, which supports the use of the mSQUASH in clinical practice and research.
引用
- van der Kraan YM, Gensler L, Paap D, et al. The mSQUASH is a feasible and valid measurement tool to uniformly assess daily physical activity in patients with rheumatic diseases. RMD Open. 2024. PMID: 39448204. doi:10.1136/rmdopen-2024-004696
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。